胰岛素使用和肝细胞癌的风险:见解和影响
Juferdy Kurniawan1, Maria Teressa
1Division of Hepatobiliary, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia - Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia. juferdy.k@gmail.com.
Acta medica Indonesiana
|April 2, 2024
概括
糖尿病患者使用胰岛素可能会增加肝细胞癌 (HCC) 的风险. 需要进一步的研究来证实这种联系,并指导高风险个体的预防策略.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 内分泌学 在内分泌学.
- 在瘤学瘤学.
背景情况:
- 糖尿病和肝细胞癌 (HCC) 的全球发病率不断上升.
- 非酒精性脂肪性肝病 (NAFLD) 的患病率增加是其中的一个因素.
- 外源胰岛素在糖尿病管理中常见的使用.
研究的目的:
- 调查胰岛素使用与患上HCC的风险之间的关联.
- 为了澄清胰岛素潜在的肝癌作用背后的机制.
- 为了解决有关胰岛素和HCC风险的相互矛盾的证据.
主要方法:
- 审查最近的研究和现有文献.
- 对糖尿病,NAFLD和HCC的流行病学数据的分析.
- 探索将胰岛素与肝癌联系在一起的生物机制.
主要成果:
- 新出现的证据表明胰岛素治疗与HCC风险增加之间存在潜在联系.
- 存在相互矛盾的数据,需要进一步验证.
- 了解胰岛素对肝细胞的特定影响至关重要.
结论:
- 胰岛素使用与HCC风险之间的关系需要进一步研究.
- 糖尿病医生和肝病学家之间的合作对于糖尿病患者的HCC预防和监测至关重要.
- 澄清胰岛素的作用对于管理日益增长的糖尿病人群中HCC风险至关重要.
相关概念视频
Insulin: Dosing Regimen and Adverse Effects
169
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
169
Insulin: The Receptor and Signaling Pathways
1.2K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
1.2K
Oral Hypoglycemic Agents: Biguanides and Glitazones
196
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
196
Diabetes Mellitus: Overview and Type I Subtype
2.6K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.6K
Diabetes Mellitus: Type 2 and Gestational
2.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.3K
Hormones Regulating Blood Glucose
3.3K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
3.3K


